Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including:Why is mpox relevant to clinical practice?Who is at highest risk for mpox?How is mpox transmitted, and what are the clinical manifestations and complications of mpox infections?What are current ACIP recommendations for mpox vaccination?What about pre- and postexposure vaccination?PresentersCarlos del Rio, MD Distinguished Professor of Medicine (Infectious Diseases)Emory University School of MedicineProfessor of Global Health and EpidemiologyRollins School of Public HealthAtlanta, GeorgiaAniruddha (Anu) Hazra, MDAssistant Professor of Medicine, Section of Infectious Disease and Global HealthDirector, Infectious Diseases Fellowship ProgramMedical Director, UCM Sexual Wellness ClinicUniversity of ChicagoChicago, IllinoisLearn more about thekey aspects of mpox infections and prevention through vaccination in our full program,“Protection Beyond Outbreaks: Routine Mpox Vaccination for Vulnerable Populations.”Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related